Beyond tumor-cell intrinsic effects, PGE2 drives myeloid-derived suppressor cell (MDSC) differentiation and suppressive programming, largely via EP2/EP4, which limits antitumor T- and NK-cell activity [45,48]. Here, PTGER4 is linked to neoplasm.